These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 722420)

  • 1. Clinical and pharmacokinetic evaluation of nafcillin in infants and children.
    Feldman WE; Nelson JD; Stanberry LR
    J Pediatr; 1978 Dec; 93(6):1029-33. PubMed ID: 722420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM; Keeley JM; Field MR; Brodeur JP
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children.
    Kaplan SL; Mason EO; Feigin RD
    South Med J; 1982 Feb; 75(2):138-42. PubMed ID: 7036354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.
    Feldman WE; Moffitt S; Sprow N
    Antimicrob Agents Chemother; 1980 Apr; 17(4):669-74. PubMed ID: 7396456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicities of methicillin and nafcillin.
    Kitzing W; Nelson JD; Mohs E
    Am J Dis Child; 1981 Jan; 135(1):52-5. PubMed ID: 7006381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
    Mader JT; Morrison LT; Adams KR
    Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
    Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of sodium nafcillin in pediatric practice.
    Nathan LA
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):701-6. PubMed ID: 4378651
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of nafcillin in infants with low birth weights.
    Banner W; Gooch WM; Burckart G; Korones SB
    Antimicrob Agents Chemother; 1980 Apr; 17(4):691-4. PubMed ID: 7396459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological tolerance in orthopaedic infections: delayed response of septic arthritis and osteomyelitis of the hip due to infection with tolerant Staphylococcus aureus.
    Thometz JG; Lamdan R; Kehl KS; Chusid MJ
    J Pediatr Orthop; 1996; 16(4):518-21. PubMed ID: 8784710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM; Keeley JM
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children.
    Ardati KO; Thirumoorthi MC; Dajani AS
    J Pediatr; 1979 Nov; 95(5 Pt 1):801-6. PubMed ID: 385814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical studies with meropenem in the pediatric field. Pediatric Study Group of Meropenem].
    Fujii R; Yoshioka H; Fujita K; Maruyama S; Sakata H; Inyaku F; Chiba S; Tsutsumi H; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1992 Jun; 45(6):697-717. PubMed ID: 1507401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.
    Kane JG; Parker RH; Jordan GW; Hoeprich PD
    Ann Intern Med; 1977 Sep; 87(3):309-11. PubMed ID: 900676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pharmacokinetic evaluation of meropenem and its effect on fecal flora in children].
    Fujita K; Murono K; Saijyo M; Yoshioka H; Maruyama S; Sakata H; Inyaku F
    Jpn J Antibiot; 1992 Jun; 45(6):718-26. PubMed ID: 1507402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.